Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	sodium:chloride symporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6	1.19e-07	17	55	4	GO:0015378
GeneOntologyMolecularFunction	monoatomic anion transmembrane transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6 GABRG3 MCOLN1 GABRA5	1.84e-07	151	55	7	GO:0008509
GeneOntologyMolecularFunction	monoatomic anion:sodium symporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6	1.94e-07	19	55	4	GO:0015373
GeneOntologyMolecularFunction	inorganic anion transmembrane transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6 GABRG3 MFSD5 GABRA5	4.29e-07	171	55	7	GO:0015103
GeneOntologyMolecularFunction	chloride:monoatomic cation symporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6	4.39e-07	23	55	4	GO:0015377
GeneOntologyMolecularFunction	monoatomic anion:monoatomic cation symporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6	7.36e-07	26	55	4	GO:0015296
GeneOntologyMolecularFunction	chloride transmembrane transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6 GABRG3 GABRA5	1.20e-06	125	55	6	GO:0015108
GeneOntologyMolecularFunction	transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6 GABRG3 ATP13A4 FLVCR1 SERINC3 XKR4 MCOLN1 GRAMD1C MFSD5 ABCB1 GABRA5	7.24e-06	1289	55	14	GO:0005215
GeneOntologyMolecularFunction	transmembrane transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6 GABRG3 ATP13A4 FLVCR1 SERINC3 MCOLN1 MFSD5 ABCB1 GABRA5	7.05e-05	1180	55	12	GO:0022857
GeneOntologyMolecularFunction	solute:sodium symporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6	7.32e-05	81	55	4	GO:0015370
GeneOntologyMolecularFunction	sodium ion transmembrane transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6 MCOLN1	1.07e-04	171	55	5	GO:0015081
GeneOntologyMolecularFunction	gamma-aminobutyric acid:sodium:chloride symporter activity	SLC6A1 SLC6A6	1.11e-04	6	55	2	GO:0005332
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6 GABRG3 ATP13A4 MCOLN1 MFSD5 GABRA5	2.07e-04	758	55	9	GO:0015318
GeneOntologyMolecularFunction	gamma-aminobutyric acid transmembrane transporter activity	SLC6A1 SLC6A6	2.65e-04	9	55	2	GO:0015185
GeneOntologyMolecularFunction	solute:monoatomic cation symporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6	3.23e-04	119	55	4	GO:0015294
GeneOntologyMolecularFunction	benzodiazepine receptor activity	GABRG3 GABRA5	4.03e-04	11	55	2	GO:0008503
GeneOntologyMolecularFunction	monoamine transmembrane transporter activity	SLC6A2 SLC6A4	4.83e-04	12	55	2	GO:0008504
GeneOntologyMolecularFunction	monocarboxylate:sodium symporter activity	SLC6A1 SLC6A6	7.64e-04	15	55	2	GO:0140161
GeneOntologyMolecularFunction	symporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6	7.75e-04	150	55	4	GO:0015293
GeneOntologyMolecularFunction	protein phosphatase activator activity	PPP2R5A PPP2R5B	9.87e-04	17	55	2	GO:0072542
GeneOntologyMolecularFunction	GABA-gated chloride ion channel activity	GABRG3 GABRA5	1.11e-03	18	55	2	GO:0022851
GeneOntologyMolecularFunction	GABA-A receptor activity	GABRG3 GABRA5	1.24e-03	19	55	2	GO:0004890
GeneOntologyMolecularFunction	secondary active monocarboxylate transmembrane transporter activity	SLC6A1 SLC6A6	1.24e-03	19	55	2	GO:0015355
GeneOntologyMolecularFunction	phospholipase A1 activity	PLA2G4B ABHD3	1.24e-03	19	55	2	GO:0008970
GeneOntologyMolecularFunction	phosphatase activator activity	PPP2R5A PPP2R5B	1.37e-03	20	55	2	GO:0019211
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6 GABRG3 ATP13A4 MCOLN1 GABRA5	1.39e-03	793	55	8	GO:0015075
GeneOntologyMolecularFunction	active monoatomic ion transmembrane transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6 ATP13A4	1.41e-03	301	55	5	GO:0022853
GeneOntologyMolecularFunction	neurotransmitter transmembrane transporter activity	SLC6A2 SLC6A4	1.51e-03	21	55	2	GO:0005326
GeneOntologyMolecularFunction	organic cation transmembrane transporter activity	SLC6A2 SLC6A6 SERINC3	1.55e-03	83	55	3	GO:0015101
GeneOntologyMolecularFunction	GABA receptor activity	GABRG3 GABRA5	1.66e-03	22	55	2	GO:0016917
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6 ATP13A4 MCOLN1	1.71e-03	465	55	6	GO:0046873
GeneOntologyMolecularFunction	amino acid:sodium symporter activity	SLC6A1 SLC6A6	1.82e-03	23	55	2	GO:0005283
GeneOntologyMolecularFunction	active transmembrane transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6 ATP13A4 ABCB1	1.94e-03	477	55	6	GO:0022804
GeneOntologyMolecularFunction	carboxylic acid transmembrane transporter activity	SLC6A1 SLC6A6 SERINC3 ABCB1	2.53e-03	207	55	4	GO:0046943
GeneOntologyMolecularFunction	organic acid transmembrane transporter activity	SLC6A1 SLC6A6 SERINC3 ABCB1	2.58e-03	208	55	4	GO:0005342
GeneOntologyMolecularFunction	monoatomic anion channel activity	GABRG3 MCOLN1 GABRA5	2.88e-03	103	55	3	GO:0005253
GeneOntologyMolecularFunction	amino acid:monoatomic cation symporter activity	SLC6A1 SLC6A6	2.88e-03	29	55	2	GO:0005416
GeneOntologyMolecularFunction	amino acid transmembrane transporter activity	SLC6A1 SLC6A6 SERINC3	3.04e-03	105	55	3	GO:0015171
GeneOntologyMolecularFunction	phospholipase activity	GDPD5 PLA2G4B ABHD3	3.83e-03	114	55	3	GO:0004620
GeneOntologyMolecularFunction	organic acid:sodium symporter activity	SLC6A1 SLC6A6	4.18e-03	35	55	2	GO:0005343
GeneOntologyMolecularFunction	phospholipase A2 activity	PLA2G4B ABHD3	4.66e-03	37	55	2	GO:0004623
GeneOntologyMolecularFunction	lipase activity	GDPD5 PLA2G4B ABHD3	6.52e-03	138	55	3	GO:0016298
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6 ATP13A4 MCOLN1	7.36e-03	627	55	6	GO:0022890
GeneOntologyMolecularFunction	ligand-gated monoatomic anion channel activity	GABRG3 GABRA5	8.38e-03	50	55	2	GO:0099095
GeneOntologyMolecularFunction	organic anion transmembrane transporter activity	SLC6A1 SLC6A6 SERINC3 ABCB1	8.61e-03	293	55	4	GO:0008514
GeneOntologyMolecularFunction	intramembrane lipid transporter activity	XKR4 ABCB1	8.71e-03	51	55	2	GO:0140303
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6	8.92e-03	296	55	4	GO:0015291
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	SLC6A1 SLC6A2 SLC6A4 SLC6A6 ATP13A4 MCOLN1	9.62e-03	664	55	6	GO:0008324
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential	GABRG3 GABRA5	1.08e-02	57	55	2	GO:1904315
GeneOntologyMolecularFunction	neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential	GABRG3 GABRA5	1.19e-02	60	55	2	GO:0099529
GeneOntologyBiologicalProcess	monoatomic anion transmembrane transport	SLC6A1 GABRG3 MCOLN1 ABCB1 GABRA5	4.96e-05	153	54	5	GO:0098656
GeneOntologyBiologicalProcess	gamma-aminobutyric acid import	SLC6A1 SLC6A6	1.00e-04	6	54	2	GO:0051939
GeneOntologyBiologicalProcess	inorganic anion transport	SLC6A1 GABRG3 MFSD5 ABCB1 GABRA5	1.07e-04	180	54	5	GO:0015698
GeneOntologyBiologicalProcess	monoatomic anion transport	SLC6A1 GABRG3 MCOLN1 ABCB1 GABRA5	1.16e-04	183	54	5	GO:0006820
GeneOntologyBiologicalProcess	neurotransmitter reuptake	SLC6A1 SLC6A2 SLC6A4	1.34e-04	38	54	3	GO:0098810
GeneOntologyBiologicalProcess	amino acid transport	SLC6A1 SLC6A2 SLC6A4 SLC6A6 SERINC3	1.56e-04	195	54	5	GO:0006865
GeneOntologyBiologicalProcess	sodium ion transmembrane transport	SLC6A1 SLC6A2 SLC6A4 SLC6A6 MCOLN1	2.10e-04	208	54	5	GO:0035725
GeneOntologyBiologicalProcess	neurotransmitter uptake	SLC6A1 SLC6A2 SLC6A4	3.42e-04	52	54	3	GO:0001504
GeneOntologyBiologicalProcess	chloride transport	SLC6A1 GABRG3 ABCB1 GABRA5	3.52e-04	128	54	4	GO:0006821
GeneOntologyBiologicalProcess	associative learning	SLC6A1 SLC6A4 ZZEF1 GABRA5	3.73e-04	130	54	4	GO:0008306
GeneOntologyBiologicalProcess	phospholipid translocation	XKR7 XKR4 ABCB1	4.04e-04	55	54	3	GO:0045332
GeneOntologyBiologicalProcess	learning or memory	SLC6A1 SLC6A4 PTCHD1 NEUROG1 ZZEF1 GABRA5	4.17e-04	373	54	6	GO:0007611
GeneOntologyBiologicalProcess	phosphatidylserine exposure on apoptotic cell surface	XKR7 XKR4	4.37e-04	12	54	2	GO:0070782
GeneOntologyBiologicalProcess	lipid translocation	XKR7 XKR4 ABCB1	5.22e-04	60	54	3	GO:0034204
GeneOntologyBiologicalProcess	regulation of membrane lipid distribution	XKR7 XKR4 ABCB1	6.61e-04	65	54	3	GO:0097035
GeneOntologyBiologicalProcess	engulfment of apoptotic cell	XKR7 XKR4	6.91e-04	15	54	2	GO:0043652
GeneOntologyBiologicalProcess	monoatomic ion transport	SLC6A1 SLC6A2 SLC6A4 SLC6A6 GABRG3 ATP13A4 FLVCR1 MCOLN1 MFSD5 ABCB1 GABRA5	7.38e-04	1374	54	11	GO:0006811
GeneOntologyBiologicalProcess	sodium ion transport	SLC6A1 SLC6A2 SLC6A4 SLC6A6 MCOLN1	7.54e-04	275	54	5	GO:0006814
GeneOntologyBiologicalProcess	cognition	SLC6A1 SLC6A4 PTCHD1 NEUROG1 ZZEF1 GABRA5	8.07e-04	423	54	6	GO:0050890
GeneOntologyCellularComponent	GABA-ergic synapse	SLC6A1 SLC6A6 GABRG3 LPAR1 GABRA5	7.09e-05	164	55	5	GO:0098982
GeneOntologyCellularComponent	postsynaptic membrane	SLC6A1 SLC6A4 SLC6A6 GABRG3 ADGRL2 LPAR1 GABRA5	8.86e-05	405	55	7	GO:0045211
GeneOntologyCellularComponent	synaptic membrane	SLC6A1 SLC6A2 SLC6A4 SLC6A6 GABRG3 ADGRL2 LPAR1 GABRA5	1.34e-04	583	55	8	GO:0097060
GeneOntologyCellularComponent	presynaptic membrane	SLC6A1 SLC6A2 SLC6A4 LPAR1 GABRA5	7.98e-04	277	55	5	GO:0042734
GeneOntologyCellularComponent	protein phosphatase type 2A complex	PPP2R5A PPP2R5B	1.01e-03	18	55	2	GO:0000159
GeneOntologyCellularComponent	GABA-A receptor complex	GABRG3 GABRA5	1.13e-03	19	55	2	GO:1902711
GeneOntologyCellularComponent	GABA receptor complex	GABRG3 GABRA5	1.38e-03	21	55	2	GO:1902710
Domain	NA_NEUROTRAN_SYMP_2	SLC6A1 SLC6A2 SLC6A4 SLC6A6	1.72e-07	18	53	4	PS00754
Domain	NA_NEUROTRAN_SYMP_3	SLC6A1 SLC6A2 SLC6A4 SLC6A6	2.17e-07	19	53	4	PS50267
Domain	SNF	SLC6A1 SLC6A2 SLC6A4 SLC6A6	2.17e-07	19	53	4	PF00209
Domain	Na/ntran_symport	SLC6A1 SLC6A2 SLC6A4 SLC6A6	2.17e-07	19	53	4	IPR000175
Domain	NA_NEUROTRAN_SYMP_1	SLC6A1 SLC6A2 SLC6A4 SLC6A6	2.17e-07	19	53	4	PS00610
Domain	FAM194	ERICH6B C3orf20	2.37e-05	3	53	2	IPR029281
Domain	FAM194	ERICH6B C3orf20	2.37e-05	3	53	2	PF14977
Domain	PP2A_B56	PPP2R5A PPP2R5B	7.86e-05	5	53	2	IPR002554
Domain	B56	PPP2R5A PPP2R5B	7.86e-05	5	53	2	PF01603
Domain	XK_rel	XKR7 XKR4	4.27e-04	11	53	2	IPR018629
Domain	XK-related	XKR7 XKR4	4.27e-04	11	53	2	PF09815
Domain	GABAA/Glycine_rcpt	GABRG3 GABRA5	1.92e-03	23	53	2	IPR006028
Domain	GPS	ADGRG7 ADGRL2	4.18e-03	34	53	2	SM00303
Domain	GPS	ADGRG7 ADGRL2	4.43e-03	35	53	2	PF01825
Domain	GPS	ADGRG7 ADGRL2	4.68e-03	36	53	2	PS50221
Domain	GPS	ADGRG7 ADGRL2	4.94e-03	37	53	2	IPR000203
Domain	WD40	FBXW10B FBXW10 WDR75 CDC20B	6.21e-03	259	53	4	PF00400
Domain	WD40	FBXW10B FBXW10 WDR75 CDC20B	7.00e-03	268	53	4	SM00320
Domain	Neurotransmitter_ion_chnl_CS	GABRG3 GABRA5	7.23e-03	45	53	2	IPR018000
Domain	WD40_repeat	FBXW10B FBXW10 WDR75 CDC20B	7.36e-03	272	53	4	IPR001680
Domain	Neur_chan_memb	GABRG3 GABRA5	7.55e-03	46	53	2	PF02932
Domain	Neur_chan_LBD	GABRG3 GABRA5	7.87e-03	47	53	2	PF02931
Domain	Neur_channel	GABRG3 GABRA5	7.87e-03	47	53	2	IPR006201
Domain	Neur_chan_lig-bd	GABRG3 GABRA5	7.87e-03	47	53	2	IPR006202
Domain	NEUROTR_ION_CHANNEL	GABRG3 GABRA5	7.87e-03	47	53	2	PS00236
Domain	Neurotrans-gated_channel_TM	GABRG3 GABRA5	7.87e-03	47	53	2	IPR006029
Domain	-	GABRG3 GABRA5	7.87e-03	47	53	2	2.70.170.10
Domain	WD_REPEATS_1	FBXW10B FBXW10 WDR75 CDC20B	7.94e-03	278	53	4	PS00678
Domain	WD_REPEATS_2	FBXW10B FBXW10 WDR75 CDC20B	8.04e-03	279	53	4	PS50082
Domain	WD_REPEATS_REGION	FBXW10B FBXW10 WDR75 CDC20B	8.04e-03	279	53	4	PS50294
Domain	TPR-contain_dom	TMTC1 NAA25 CFAP70	8.87e-03	150	53	3	IPR013026
Domain	G_PROTEIN_RECEP_F2_2	ADGRG7 ADGRL2	8.87e-03	50	53	2	PS00650
Domain	7tm_2	ADGRG7 ADGRL2	8.87e-03	50	53	2	PF00002
Domain	TPR_8	TMTC1 CFAP70	9.93e-03	53	53	2	PF13181
Domain	WD40_repeat_dom	FBXW10B FBXW10 WDR75 CDC20B	9.96e-03	297	53	4	IPR017986
Domain	WD40_repeat_CS	FBXW10B FBXW10 CDC20B	1.13e-02	164	53	3	IPR019775
Domain	TPR	TMTC1 NAA25 CFAP70	1.15e-02	165	53	3	PS50005
Domain	TPR_REGION	TMTC1 NAA25 CFAP70	1.15e-02	165	53	3	PS50293
Domain	GPCR_2-like	ADGRG7 ADGRL2	1.26e-02	60	53	2	IPR017981
Domain	GPCR_2_secretin-like	ADGRG7 ADGRL2	1.26e-02	60	53	2	IPR000832
Pathway	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	SLC6A1 SLC6A2 SLC6A6	1.57e-05	19	37	3	M27362
Pathway	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	SLC6A1 SLC6A2 SLC6A6	1.57e-05	19	37	3	MM15107
Pathway	WP_GABA_RECEPTOR_SIGNALING	SLC6A1 GABRG3 GABRA5	7.11e-05	31	37	3	M39369
Pathway	WP_MONOAMINE_TRANSPORT	SLC6A1 SLC6A2 SLC6A4	7.83e-05	32	37	3	M39724
Pathway	WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME	PPP2R5A PPP2R5B PDS5A	9.42e-05	34	37	3	M42555
Pathway	WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION	SLC6A1 SLC6A2 SLC6A4 ITGA6	3.82e-04	132	37	4	M48110
Pathway	WP_NRF2_PATHWAY	SLC6A1 SLC6A2 SLC6A4 SLC6A6	4.90e-04	141	37	4	M39454
Pathway	REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS	PPP2R5A PPP2R5B	6.89e-04	15	37	2	M27407
Pathway	KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE	PPP2R5A PPP2R5B	7.86e-04	16	37	2	M47870
Pathway	REACTOME_PLATELET_SENSITIZATION_BY_LDL	PPP2R5A PPP2R5B	8.89e-04	17	37	2	MM15096
Pathway	REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE	PPP2R5A PPP2R5B	8.89e-04	17	37	2	M27083
Pathway	REACTOME_PLATELET_SENSITIZATION_BY_LDL	PPP2R5A PPP2R5B	8.89e-04	17	37	2	M919
Pathway	REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE	PPP2R5A PPP2R5B	9.99e-04	18	37	2	MM14759
Pathway	REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	SLC6A1 SLC6A2 SLC6A6	1.03e-03	76	37	3	MM15072
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING	JAK1 PPP2R5A PPP2R5B ITGA6 LPAR1	1.08e-03	302	37	5	M39719
Pathway	KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY	PPP2R5A PPP2R5B	1.11e-03	19	37	2	M47525
Pathway	KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING	PPP2R5A PPP2R5B	1.24e-03	20	37	2	M47876
Pathway	WP_NUCLEAR_RECEPTORS_METAPATHWAY	SLC6A1 SLC6A2 SLC6A4 SLC6A6 ABCB1	1.29e-03	314	37	5	M39428
Pathway	REACTOME_CTLA4_INHIBITORY_SIGNALING	PPP2R5A PPP2R5B	1.36e-03	21	37	2	M5876
Pathway	REACTOME_CTLA4_INHIBITORY_SIGNALING	PPP2R5A PPP2R5B	1.36e-03	21	37	2	MM14996
Pathway	REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	SLC6A1 SLC6A2 SLC6A6	1.37e-03	84	37	3	M27334
Pathway	KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY	PPP2R5A PPP2R5B	1.50e-03	22	37	2	M47919
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY	JAK1 PPP2R5A PPP2R5B ITGA6 LPAR1	1.52e-03	326	37	5	MM15917
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	SLC6A1 SLC6A2 SLC6A6 ATP13A4 FLVCR1 MCOLN1 ABCB1	1.72e-03	681	37	7	MM14985
Pathway	WP_PI3KAKT_SIGNALING	JAK1 PPP2R5A PPP2R5B ITGA6 LPAR1	1.81e-03	339	37	5	M39736
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	SLC6A1 SLC6A4 GABRG3 GABRA5	2.19e-03	211	37	4	MM14502
Pathway	WP_IL6_SIGNALING_PATHWAY	JAK1 PPP2R5A PPP2R5B	2.26e-03	100	37	3	MM15826
Pubmed	The repertoire of solute carriers of family 6: identification of new human and rodent genes.	SLC6A1 SLC6A2 SLC6A4 SLC6A6	3.53e-08	21	56	4	16125675
Pubmed	Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.	SLC6A2 SLC6A4 ABCB1	1.38e-07	7	56	3	19844206
Pubmed	Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.	SLC6A1 SLC6A2 SLC6A4 GABRG3 NEUROG1 ABCB1 GABRA5	5.35e-07	300	56	7	19086053
Pubmed	A common variant in DRD3 receptor is associated with autism spectrum disorder.	SLC6A1 SLC6A2 SLC6A4 GABRG3 GABRA5	2.05e-06	128	56	5	19058789
Pubmed	SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcome.	SLC6A2 SLC6A4	2.55e-06	2	56	2	25295552
Pubmed	Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.	SLC6A2 SLC6A4	2.55e-06	2	56	2	15337646
Pubmed	Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression.	SLC6A2 SLC6A4	2.55e-06	2	56	2	25650523
Pubmed	FBXW10 promotes hepatocarcinogenesis in male patients and mice.	FBXW10B FBXW10	2.55e-06	2	56	2	31400758
Pubmed	Combination of the serotonin transporter and norepinephrine transporter gene promoter polymorphisms might influence harm avoidance and novelty seeking in healthy females.	SLC6A2 SLC6A4	2.55e-06	2	56	2	18511195
Pubmed	Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects.	SLC6A2 SLC6A4	2.55e-06	2	56	2	24346757
Pubmed	[Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].	SLC6A2 SLC6A4	2.55e-06	2	56	2	20491280
Pubmed	HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression.	SLC6A1 SLC6A4	2.55e-06	2	56	2	18005940
Pubmed	[Association of serotonin and norepinephrine transporter gene polymorphisms with the susceptibility to depression].	SLC6A2 SLC6A4	2.55e-06	2	56	2	20017301
Pubmed	Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice.	FBXW10B FBXW10	2.55e-06	2	56	2	37450367
Pubmed	Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.	SLC6A2 SLC6A4	2.55e-06	2	56	2	19468717
Pubmed	Norepinephrine and serotonin transporter genes: impact on treatment response in depression.	SLC6A2 SLC6A4	2.55e-06	2	56	2	20588071
Pubmed	A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception.	SLC6A2 SLC6A4	2.55e-06	2	56	2	21129446
Pubmed	Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.	SLC6A2 SLC6A4	2.55e-06	2	56	2	23086945
Pubmed	An analysis paradigm for investigating multi-locus effects in complex disease: examination of three GABA receptor subunit genes on 15q11-q13 as risk factors for autistic disorder.	GABRG3 GABRA5	7.63e-06	3	56	2	16674551
Pubmed	An association study in the Taiwan Biobank elicits the GABAA receptor genes GABRB3, GABRA5, and GABRG3 as candidate loci for sleep duration in the Taiwanese population.	GABRG3 GABRA5	7.63e-06	3	56	2	34530807
Pubmed	Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice.	SLC6A2 SLC6A4	7.63e-06	3	56	2	19482066
Pubmed	Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression.	SLC6A2 SLC6A4	7.63e-06	3	56	2	19649213
Pubmed	Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas.	SLC6A2 SLC6A4	7.63e-06	3	56	2	20332182
Pubmed	Meta-Analysis of the Association between GABA Receptor Polymorphisms and Autism Spectrum Disorder (ASD).	GABRG3 GABRA5	7.63e-06	3	56	2	29725984
Pubmed	Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.	SLC6A2 SLC6A4	7.63e-06	3	56	2	12401330
Pubmed	GABA Receptor SNPs and Elevated Plasma GABA Levels Affect the Severity of the Indian ASD Probands.	GABRG3 GABRA5	7.63e-06	3	56	2	35562522
Pubmed	Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders.	SLC6A2 SLC6A4	7.63e-06	3	56	2	15138209
Pubmed	Serotonin transporter gene and adverse life events in adult ADHD.	SLC6A2 SLC6A4	7.63e-06	3	56	2	18214863
Pubmed	The gamma-aminobutyric acid receptor gamma 3 subunit gene (GABRG3) is tightly linked to the alpha 5 subunit gene (GABRA5) on human chromosome 15q11-q13 and is transcribed in the same orientation.	GABRG3 GABRA5	7.63e-06	3	56	2	7601451
Pubmed	Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.	SLC6A1 SLC6A2	7.63e-06	3	56	2	18690111
Pubmed	No evidence for significant association between GABA receptor genes in chromosome 15q11-q13 and autism in a Japanese population.	GABRG3 GABRA5	7.63e-06	3	56	2	17957331
Pubmed	Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study.	SLC6A2 SLC6A4	1.52e-05	4	56	2	18937309
Pubmed	GABAA-receptor alpha-subunit is an essential prerequisite for receptor formation in vivo.	GABRG3 GABRA5	1.52e-05	4	56	2	9330366
Pubmed	Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans.	SLC6A2 SLC6A4	1.52e-05	4	56	2	16848906
Pubmed	Hypotaurine Is a Substrate of GABA Transporter Family Members GAT2/Slc6a13 and TAUT/Slc6a6.	SLC6A1 SLC6A6	1.52e-05	4	56	2	30270321
Pubmed	A cluster of three GABAA receptor subunit genes is deleted in a neurological mutant of the mouse p locus.	GABRG3 GABRA5	1.52e-05	4	56	2	8392662
Pubmed	Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1.	SLC6A2 SLC6A4	1.52e-05	4	56	2	11343649
Pubmed	Concordance between isolated cleft palate in mice and alterations within a region including the gene encoding the beta 3 subunit of the type A gamma-aminobutyric acid receptor.	GABRG3 GABRA5	1.52e-05	4	56	2	8389469
Pubmed	Phenotypic consequences of deletion of the gamma 3, alpha 5, or beta 3 subunit of the type A gamma-aminobutyric acid receptor in mice.	GABRG3 GABRA5	1.52e-05	4	56	2	8146195
Pubmed	The variable subunit associated with protein phosphatase 2A0 defines a novel multimember family of regulatory subunits.	PPP2R5A PPP2R5B	2.54e-05	5	56	2	8694763
Pubmed	Assignment of human protein phosphatase 2A regulatory subunit genes b56alpha, b56beta, b56gamma, b56delta, and b56epsilon (PPP2R5A-PPP2R5E), highly expressed in muscle and brain, to chromosome regions 1q41, 11q12, 3p21, 6p21.1, and 7p11.2 --> p12.	PPP2R5A PPP2R5B	2.54e-05	5	56	2	8812429
Pubmed	FBXW10-S6K1 promotes ANXA2 polyubiquitination and KRAS activation to drive hepatocellular carcinoma development in males.	FBXW10B FBXW10	2.54e-05	5	56	2	37277019
Pubmed	Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers.	SLC6A2 SLC6A4	2.54e-05	5	56	2	18197080
Pubmed	Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine.	SLC6A1 SLC6A4	2.54e-05	5	56	2	17544870
Pubmed	Genomic organisation, chromosomal localisation tissue distribution and developmental regulation of the PR61/B' regulatory subunits of protein phosphatase 2A in mice.	PPP2R5A PPP2R5B	2.54e-05	5	56	2	15095873
Pubmed	Mapping of putative ether-anesthesia resistance gene using C57BL/6J and MSM/Ms mouse strains.	GABRG3 GABRA5	2.54e-05	5	56	2	15549469
Pubmed	Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3.	SLC6A2 SLC6A4	3.80e-05	6	56	2	20858707
Pubmed	Independent assembly and subcellular targeting of GABA(A)-receptor subtypes demonstrated in mouse hippocampal and olfactory neurons in vivo.	GABRG3 GABRA5	3.80e-05	6	56	2	9682826
Pubmed	Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies.	SLC6A2 SLC6A4	3.80e-05	6	56	2	15135235
Pubmed	Physical mapping of the pink-eyed dilution complex in mouse chromosome 7 shows that Atp10c is the only transcript between Gabrb3 and Ube3a.	GABRG3 GABRA5	3.80e-05	6	56	2	15620220
Pubmed	Expression and immunolocalization of the plasma membrane monoamine transporter in the brain.	SLC6A2 SLC6A4	3.80e-05	6	56	2	17408864
Pubmed	A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.	SLC6A2 SLC6A4	3.80e-05	6	56	2	19858760
Pubmed	The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm.	PPP2R5A PPP2R5B	5.32e-05	7	56	2	8703017
Pubmed	Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism.	GABRG3 GABRA5	5.32e-05	7	56	2	16080114
Pubmed	Identification of a new family of protein phosphatase 2A regulatory subunits.	PPP2R5A PPP2R5B	5.32e-05	7	56	2	7592815
Pubmed	Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients.	SLC6A4 ABCB1	7.09e-05	8	56	2	20110084
Pubmed	Serotonin transporter protects the placental cells against apoptosis in caspase 3-independent pathway.	SLC6A2 SLC6A4	7.09e-05	8	56	2	28109119
Pubmed	Direct binding between BubR1 and B56-PP2A phosphatase complexes regulate mitotic progression.	PPP2R5A PPP2R5B	9.10e-05	9	56	2	23345399
Pubmed	De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.	PPP2R5A PPP2R5B	9.10e-05	9	56	2	30595372
Pubmed	IRIP, a new ischemia/reperfusion-inducible protein that participates in the regulation of transporter activity.	SLC6A2 SLC6A4	9.10e-05	9	56	2	16024787
Pubmed	Exposure of phosphatidylserine by Xk-related protein family members during apoptosis.	XKR7 XKR4	1.14e-04	10	56	2	25231987
Pubmed	A microsatellite map of the pink-eyed dilution (p) deletion complex in mouse chromosome 7.	GABRG3 GABRA5	1.14e-04	10	56	2	9060416
Pubmed	Genomic annotation of 15,809 ESTs identified from pooled early gestation human eyes.	EBPL FLVCR1 PAPPA	1.40e-04	62	56	3	16368877
Pubmed	Regulation of Chk2 phosphorylation by interaction with protein phosphatase 2A via its B' regulatory subunit.	PPP2R5A PPP2R5B	1.66e-04	12	56	2	15380617
Pubmed	Genome-wide association study identifies a novel susceptibility gene for serum TSH levels in Chinese populations.	TMEM68 XKR4	1.66e-04	12	56	2	24852370
Pubmed	Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I.	PPP2R5A PPP2R5B	1.66e-04	12	56	2	16541024
Pubmed	PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins.	PPP2R5A PPP2R5B	1.96e-04	13	56	2	21072166
Pubmed	Association study of 182 candidate genes in anorexia nervosa.	SLC6A2 SLC6A4 GABRG3 GABRA5	2.15e-04	182	56	4	20468064
Pubmed	Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr.	PPP2R5A PPP2R5B	2.29e-04	14	56	2	9013886
Pubmed	Increasing the ratio of PP2A core enzyme to holoenzyme inhibits Tat-stimulated HIV-1 transcription and virus production.	PPP2R5A PPP2R5B	2.29e-04	14	56	2	9400615
Pubmed	Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription.	PPP2R5A PPP2R5B	2.29e-04	14	56	2	16048649
Pubmed	Aurora B and Cdk1 mediate Wapl activation and release of acetylated cohesin from chromosomes by phosphorylating Sororin.	PPP2R5A PDS5A	2.64e-04	15	56	2	23901111
Pubmed	A pilot multivariate parallel ICA study to investigate differential linkage between neural networks and genetic profiles in schizophrenia.	SLC6A2 SLC6A4	2.64e-04	15	56	2	19944766
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	JAK1 SLC6A6 EMC3 ITGA6 PDS5A TMEM68 LPAR1 MFSD5	2.83e-04	1061	56	8	33845483
Pubmed	Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene.	SLC6A2 SLC6A4	3.01e-04	16	56	2	19693267
Pubmed	Molecular analysis of 36 mutations at the mouse pink-eyed dilution (p) locus.	GABRG3 GABRA5	3.01e-04	16	56	2	8601494
Pubmed	Regulation of HIV-1 transcription by protein phosphatase 1.	PPP2R5A PPP2R5B	3.41e-04	17	56	2	17266553
Pubmed	[Action of protein phosphatase-1 on Tat-dependent HIV-1 transcription and its related inhibitors].	PPP2R5A PPP2R5B	3.41e-04	17	56	2	21351466
Pubmed	Molecular mechanisms involved in HIV-1-Tat mediated inhibition of telomerase activity in human CD4(+) T lymphocytes.	PPP2R5A PPP2R5B	3.83e-04	18	56	2	23287597
Pubmed	Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters.	SLC6A6 ABCB1	3.83e-04	18	56	2	31791063
Pubmed	Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype.	GABRG3 GABRA5	3.83e-04	18	56	2	19078961
Pubmed	Candidate gene studies of ADHD: a meta-analytic review.	SLC6A2 SLC6A4	3.83e-04	18	56	2	19506906
Pubmed	GABA neurotransmitter signaling in the developing mouse lens: dynamic regulation of components and functionality.	SLC6A1 GABRG3	3.83e-04	18	56	2	18985723
Pubmed	Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.	SLC6A2 SLC6A4	4.28e-04	19	56	2	19095219
Pubmed	Shugoshin collaborates with protein phosphatase 2A to protect cohesin.	PPP2R5A PPP2R5B	4.28e-04	19	56	2	16541025
Pubmed	A functional cellular framework for sex and estrous cycle-dependent gene expression and behavior.	PTCHD1 PAPPA	6.30e-04	23	56	2	35065713
Pubmed	Blood-Brain Barrier: From Physiology to Disease and Back.	SLC6A1 SLC6A6 ABCB1	6.60e-04	105	56	3	30280653
Pubmed	Developmental abnormalities in cortical GABAergic system in mice lacking mGlu3 metabotropic glutamate receptors.	SLC6A1 GABRA5	7.46e-04	25	56	2	31665922
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	NAA25 EMC3 FLVCR1 PXMP2 PDS5A ADGRL2 ILVBL	7.64e-04	942	56	7	31073040
Pubmed	HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25.	PPP2R5A PPP2R5B	8.07e-04	26	56	2	11531413
Pubmed	Reconstruction of phrenic neuron identity in embryonic stem cell-derived motor neurons.	PAPPA MMD2	8.71e-04	27	56	2	24496616
Pubmed	Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: suggestive association signals in ADRA1A.	SLC6A2 SLC6A4	9.37e-04	28	56	2	19352218
Pubmed	The human and mouse repertoire of the adhesion family of G-protein-coupled receptors.	ADGRG7 ADGRL2	1.01e-03	29	56	2	15203201
Pubmed	Genetic associations of brain structural networks in schizophrenia: a preliminary study.	SLC6A2 SLC6A4	1.15e-03	31	56	2	20691427
Pubmed	Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation.	GABRG3 GABRA5	1.15e-03	31	56	2	19736351
Pubmed	miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network.	SLC6A1 SLC6A6	1.15e-03	31	56	2	37816598
Pubmed	Genetical genomic determinants of alcohol consumption in rats and humans.	SLC6A2 SLC6A4 GABRG3	1.22e-03	130	56	3	19874574
Pubmed	International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.	ADGRG7 ADGRL2	1.30e-03	33	56	2	25713288
Pubmed	Absence of S100A4 in the mouse lens induces an aberrant retina-specific differentiation program and cataract.	SLC6A1 SLC6A6	1.38e-03	34	56	2	33500475
Pubmed	Prdm12 represses the expression of the visceral neuron determinants Phox2a/b in developing somatosensory ganglia.	SLC6A2 NEUROG1	1.46e-03	35	56	2	38025786
Cytoband	Ensembl 112 genes in cytogenetic band chr3p25	SLC6A1 SLC6A6 EMC3 C3orf20	3.47e-05	155	54	4	chr3p25
Cytoband	15q12	GABRG3 GABRA5	4.86e-05	9	54	2	15q12
Cytoband	Ensembl 112 genes in cytogenetic band chr15q12	GABRG3 GABRA5	2.05e-04	18	54	2	chr15q12
Cytoband	8q12.1	TMEM68 XKR4	5.40e-04	29	54	2	8q12.1
Cytoband	3p25.1	SLC6A6 C3orf20	7.88e-04	35	54	2	3p25.1
Cytoband	3p25.3	SLC6A1 EMC3	1.30e-03	45	54	2	3p25.3
Cytoband	17p12	FBXW10B FBXW10	1.54e-03	49	54	2	17p12
Cytoband	Ensembl 112 genes in cytogenetic band chr8q12	TMEM68 XKR4	5.31e-03	92	54	2	chr8q12
GeneFamily	WD repeat domain containing\|F-box and WD repeat domain containing	FBXW10B FBXW10	2.59e-04	11	40	2	559
GeneFamily	Blood group antigens\|XK related family	XKR7 XKR4	2.59e-04	11	40	2	955
GeneFamily	WD repeat domain containing\|Protein phosphatase 2 regulatory subunits	PPP2R5A PPP2R5B	4.92e-04	15	40	2	696
GeneFamily	Gamma-aminobutyric acid type A receptor subunits	GABRG3 GABRA5	7.97e-04	19	40	2	563
GeneFamily	Solute carriers	SLC6A1 SLC6A2 SLC6A4 SLC6A6 FLVCR1	1.70e-03	395	40	5	752
GeneFamily	WD repeat domain containing	FBXW10B FBXW10 WDR75 CDC20B	2.61e-03	262	40	4	362
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#1_top-relative-expression-ranked_1000	JAK1 ABHD3 SERINC3 MMD2 MMD2	2.43e-05	141	52	5	gudmap_developingGonad_P2_ovary_1000_k1
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4 LPAR1	3.59e-06	192	54	5	dc40ef2341e5d6a6d479f140e023fe1bf687928d
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SLC6A4 TMTC1 ITGA6 ADGRL2 ABCB1	3.77e-06	194	54	5	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SLC6A4 TMTC1 ITGA6 ADGRL2 ABCB1	3.77e-06	194	54	5	40842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GDPD5 PPP2R5A ITGA6 ADGRL2 ABCB1	4.06e-06	197	54	5	b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SLC6A1 TMTC1 PAPPA XKR4 LPAR1	4.37e-06	200	54	5	347a510755374c6a66acee326565dfc447993f18
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRG7 ITGA6 PAPPA ABCB1	1.94e-05	131	54	4	d706405453408fbcfcabb1c7702b80f9e649ffca
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRG7 ERICH6B XKR4 LPAR1	4.24e-05	160	54	4	14dfa519e68bab4bce890ddb66fa7763f18d9f19
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRG7 ERICH6B XKR4 LPAR1	4.24e-05	160	54	4	5b7789d4668ed7732babedc32d812233b430e0bd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRG7 ERICH6B XKR4 LPAR1	4.24e-05	160	54	4	bba1486faaad5299e10f4fe17c6d149c28dc2560
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRG7 ERICH6B XKR4 LPAR1	4.24e-05	160	54	4	839bbdfd4e4c7b48260c8bfb7670378634405e1d
ToppCell	Endothelial-endothelial_cell_of_bronchial_vessel\|World / Lineage, Cell type, age group and donor	TMTC1 ITGA6 ADGRL2 ABCB1	4.78e-05	165	54	4	84e553d699ac56df89a77248f7308b9133e1b683
ToppCell	PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC6A4 GABRG3 ITGA6 GRAMD1C	5.62e-05	172	54	4	e39ea2f4edbf36ebf9604fa6f9349081859c596c
ToppCell	PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC6A4 GABRG3 ITGA6 GRAMD1C	5.62e-05	172	54	4	bcc50bed47465daa953ba91f17d1ee4c947ab461
ToppCell	PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC6A4 GABRG3 ITGA6 GRAMD1C	5.62e-05	172	54	4	875ea290840e835952623b905eb610f3c71456d2
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 FBXW10 PXMP2 MMD2	7.30e-05	184	54	4	6b0c110d8930df99043c3b99cf4d873985126960
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 FBXW10 PXMP2 MMD2	7.30e-05	184	54	4	35928fc5f7bbf8c7b09181a2bd27e22dff42ec16
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A1 ATP13A4 PXMP2 MMD2	7.30e-05	184	54	4	f6148e9591e8845cc62668e49fd52755257cdc7e
ToppCell	COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	TMTC1 ITGA6 ADGRL2 ABCB1	7.45e-05	185	54	4	f5e14181f45c37d13ee9e017a4c8bc248c353676
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231\|Adult / Lineage, Cell type, age group and donor	SLC6A4 TMTC1 ITGA6 ADGRL2	7.45e-05	185	54	4	07f9f38f0739d7c830641723a38385550ac1ac92
ToppCell	5'-Adult-LargeIntestine-Neuronal-Glial_mature\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PAPPA XKR4 MMD2 GABRA5	7.45e-05	185	54	4	f607b6ee579562e2f92103fa5c7053df0170a229
ToppCell	5'-Adult-LargeIntestine-Neuronal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PAPPA XKR4 MMD2 GABRA5	7.45e-05	185	54	4	317f2c854f00aa5957319b818c85eeed7d72ec7f
ToppCell	5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PAPPA XKR4 MMD2 GABRA5	7.45e-05	185	54	4	7bb8fdfe04f85d25056380ec58222366de323a21
ToppCell	Control-Endothelial-Endothelial-Vein\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC6A6 PTCHD1 ITGA6 ABCB1	7.61e-05	186	54	4	92092f11ecce22c14f244e42c499af0822977e6f
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175\|Adult / Lineage, Cell type, age group and donor	SLC6A4 TMTC1 ITGA6 ADGRL2	7.77e-05	187	54	4	f3548817f2fded5978137bb252cb628ac199e4f6
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	7.77e-05	187	54	4	85f1678338a47d91e296f0620d4887f057eb7e70
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SLC6A4 TMTC1 ADGRL2 ABCB1	7.77e-05	187	54	4	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122\|Adult / Lineage, Cell type, age group and donor	SLC6A4 TMTC1 ITGA6 ADGRL2	7.93e-05	188	54	4	02a62888e9db29d20133eeca1686d302545a39c9
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	TMTC1 ITGA6 ADGRL2 ABCB1	7.93e-05	188	54	4	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	facs-Skin-nan-18m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A2 SLC6A4 PPP2R5A FLVCR1	8.10e-05	189	54	4	6c71e81373cb7822de23c193a6350b6df9f567bc
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMTC1 PPP2R5A SERINC3 ADGRL2	8.10e-05	189	54	4	09dd2b3d89416192e84abe302a6237b8f3fdcb6e
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.10e-05	189	54	4	06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.26e-05	190	54	4	d19bc44310c53726e2f5f6a2bd377bbbf1d1983f
ToppCell	Endothelial-A-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	SLC6A4 TMTC1 ADGRL2 ABCB1	8.26e-05	190	54	4	6e83fa0eb8cabe0ffb35375f16e6bf3755ec4977
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	SLC6A4 TMTC1 ITGA6 ADGRL2	8.26e-05	190	54	4	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	COVID-19-Heart-EC_3\|Heart / Disease (COVID-19 only), tissue and cell type	TMTC1 ITGA6 ADGRL2 ABCB1	8.26e-05	190	54	4	78e7c502b0450c0b37652b1896a2a752fd8a2111
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SLC6A4 TMTC1 ADGRL2 ABCB1	8.26e-05	190	54	4	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	droplet-Skin-nan-21m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A4 SLC6A6 ITGA6 ADGRL2	8.26e-05	190	54	4	c1bfc1960a3df49c0f459454a7363804c32418ee
ToppCell	Control-Endothelial-VE_Capillary_B\|Control / Disease state, Lineage and Cell class	SLC6A4 TMTC1 ITGA6 ADGRL2	8.43e-05	191	54	4	322237793a1278bafb14e63cab688b353e352dcc
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A1 ATP13A4 ABHD3 MMD2	8.43e-05	191	54	4	fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.43e-05	191	54	4	de54dab85db70f847de75b3b6d7667a0e13b9bfb
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.43e-05	191	54	4	9c0ee270209b02043393416ecc9a81ddedfbb8b6
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPP2R5A ITGA6 ADGRL2 ABCB1	8.60e-05	192	54	4	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A1 ATP13A4 ABHD3 MMD2	8.60e-05	192	54	4	261211a86e6f63b09c2ddce1d2d9257d311f1770
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPP2R5A ITGA6 ADGRL2 ABCB1	8.60e-05	192	54	4	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA6 SERINC3 HAS1 ADGRL2	8.78e-05	193	54	4	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 GDPD5 PAPPA XKR4	8.78e-05	193	54	4	53bcd50892c379b2a571751f6eb1062436339fe7
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.78e-05	193	54	4	d1445b8bf2bab36e1a326ddb2a528151db016c7d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.78e-05	193	54	4	4979862c0c16e6b4baa4c79894f1d237c861f5a5
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.78e-05	193	54	4	8b77625bf3c87d39767fb391d1beaca4ab02342b
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.78e-05	193	54	4	2c15186d15545804cc262da9137ab825609d4b2c
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.78e-05	193	54	4	010717ca052b6c8a525a43aaeffddea0d1113e63
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA6 SERINC3 HAS1 ADGRL2	8.78e-05	193	54	4	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.78e-05	193	54	4	3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPP2R5A ITGA6 ADGRL2 ABCB1	8.78e-05	193	54	4	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPP2R5A ITGA6 ADGRL2 ABCB1	8.78e-05	193	54	4	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.78e-05	193	54	4	2189da4b727e25e62669d7b9257f06493be21a27
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPP2R5A ITGA6 ADGRL2 ABCB1	8.78e-05	193	54	4	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.78e-05	193	54	4	e74fdc8718fe0933e1f4dd3fe37e2134983b99b6
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.78e-05	193	54	4	658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA6 SERINC3 HAS1 ADGRL2	8.78e-05	193	54	4	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPP2R5A ITGA6 ADGRL2 ABCB1	8.78e-05	193	54	4	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SLC6A4 TMTC1 ITGA6 ADGRL2	8.78e-05	193	54	4	ad3f4fcc8e2816d696cbcde744dc16500e51ccac
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPP2R5A ITGA6 ADGRL2 ABCB1	8.78e-05	193	54	4	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)\|Adult / Lineage, Cell type, age group and donor	SLC6A4 TMTC1 ITGA6 ADGRL2	8.78e-05	193	54	4	39c6c96a2a100b1b290a779d36cc6bc17245720b
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPP2R5A ITGA6 ADGRL2 ABCB1	8.78e-05	193	54	4	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA6 SERINC3 HAS1 ADGRL2	8.78e-05	193	54	4	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.78e-05	193	54	4	5581a5ebcd21a2a8062ccfb917f088ec67a10a9c
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SLC6A4 TMTC1 ITGA6 ADGRL2	8.95e-05	194	54	4	68004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A1 TMTC1 PAPPA XKR4	8.95e-05	194	54	4	e5990880961d2469759ce4b3b20ae93ace3ebd1f
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMTC1 ITGA6 ADGRL2 ABCB1	8.95e-05	194	54	4	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMTC1 ITGA6 ADGRL2 ABCB1	8.95e-05	194	54	4	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMTC1 ITGA6 ADGRL2 ABCB1	8.95e-05	194	54	4	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	Adult-Endothelial\|Adult / Lineage, Cell type, age group and donor	SLC6A4 TMTC1 ITGA6 ADGRL2	8.95e-05	194	54	4	963b3fbee0575af8379baa397ace65949eaf34f7
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMTC1 ITGA6 ADGRL2 ABCB1	8.95e-05	194	54	4	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMTC1 ITGA6 ADGRL2 ABCB1	9.13e-05	195	54	4	56efeb58df19f357d7d5ce87348d4f196a595421
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SLC6A4 TMTC1 ITGA6 ADGRL2	9.13e-05	195	54	4	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JAK1 SERINC3 HAS1 ADGRL2	9.13e-05	195	54	4	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SLC6A4 TMTC1 ITGA6 ADGRL2	9.32e-05	196	54	4	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	Endothelial\|World / Lineage, Cell type, age group and donor	SLC6A4 TMTC1 ITGA6 ADGRL2	9.32e-05	196	54	4	96c6d78482a130ce4e29f6629972a06d10d7530e
ToppCell	Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC6A1 TMTC1 ITGA6 LPAR1	9.50e-05	197	54	4	dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	SLC6A4 TMTC1 ITGA6 ADGRL2	9.50e-05	197	54	4	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC6A4 TMTC1 ITGA6 ADGRL2	9.50e-05	197	54	4	81718164c9802ee20c860ffbda7e62d5e9a76f16
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC6A4 TMTC1 ITGA6 ADGRL2	9.69e-05	198	54	4	1d30a1f73b6d6d838f49751402a29c5ef54aa81f
ToppCell	COVID-19-lung-Capillary_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SLC6A4 TMTC1 ITGA6 ADGRL2	9.69e-05	198	54	4	45419f2804b4be79bae6632e71c54e1af482d115
ToppCell	Endoth-Vasc\|World / shred by cell class for parenchyma	TMTC1 ITGA6 ADGRL2 ABCB1	9.69e-05	198	54	4	067101d070cfaf84c7d16c6e517f8946690ad502
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SLC6A4 TMTC1 ITGA6 ADGRL2	9.88e-05	199	54	4	3fea92affacd4c1f588fa81807df35d6c69b7241
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	SLC6A4 TMTC1 ITGA6 ADGRL2	9.88e-05	199	54	4	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Endothelial-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	SLC6A4 TMTC1 ITGA6 ADGRL2	9.88e-05	199	54	4	edb68a4f622a494f22fd7b25bc40ae0d58456cdb
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLC6A4 TMTC1 ITGA6 ADGRL2	9.88e-05	199	54	4	993999adf346b4fd557989bc53c17eb0ccb996c9
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SLC6A4 TMTC1 ITGA6 ADGRL2	9.88e-05	199	54	4	523e01f6a0abd9820697572e042a381aae8932dc
ToppCell	Parenchymal-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC6A4 TMTC1 ITGA6 ADGRL2	9.88e-05	199	54	4	a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC6A4 TMTC1 ITGA6 ADGRL2	9.88e-05	199	54	4	d58edc5f74970bb26d844746184e4bae7c494d6b
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TMTC1 ITGA6 ADGRL2 ABCB1	9.88e-05	199	54	4	e2d5c5cab102e67b0131b02392d81adaedc15965
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLC6A4 TMTC1 ITGA6 ADGRL2	9.88e-05	199	54	4	45f9c03d2ed2d98d66086fb0251bd24e30c6f775
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLC6A4 TMTC1 ITGA6 ADGRL2	9.88e-05	199	54	4	448dd5a27d57627468c6b8347f1b6b1005aea004
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLC6A4 TMTC1 ITGA6 ADGRL2	9.88e-05	199	54	4	0d0d5cb821db16514192ad536849a8a04e22e637
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Capillary\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SLC6A4 TMTC1 ITGA6 ADGRL2	9.88e-05	199	54	4	89f4db619fbed90f7fdf6ece7a671e514b5c6d76
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SLC6A4 TMTC1 ITGA6 ADGRL2	9.88e-05	199	54	4	dfd60380a29f99e187050933ee5252ec11c68a32
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PPP2R5A ITGA6 SERINC3 ADGRL2	1.01e-04	200	54	4	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SLC6A1 TMTC1 PAPPA XKR4	1.01e-04	200	54	4	858421b91f5207b7934b5c219752cb9322a3da31
Computational	Genes in the cancer module 162.	SLC6A1 SLC6A2 SLC6A4	1.49e-05	19	28	3	MODULE_162
Computational	Genes in the cancer module 218.	SLC6A1 SLC6A2 SLC6A4	1.75e-05	20	28	3	MODULE_218
Drug	Fluorescent Dyes	SLC6A2 SLC6A4 ABCB1	4.76e-08	4	53	3	ctd:D005456
Drug	methanethiosulfonate	SLC6A1 SLC6A2 SLC6A4 GABRG3 ABCB1 GABRA5	1.43e-07	103	53	6	CID004188587
Drug	pseudoisocyanin	SLC6A2 SLC6A4 ABCB1	4.14e-07	7	53	3	CID000075462
Drug	NO-711	SLC6A1 SLC6A2 SLC6A4 GABRG3 GABRA5	4.52e-07	66	53	5	CID000004515
Drug	flurazepam	SLC6A1 GABRG3 ABCB1 GABRA5	1.30e-06	35	53	4	CID000003393
Drug	Desvenlafaxine	SLC6A2 SLC6A4	5.32e-06	2	53	2	DB06700
Drug	Protriptyline	SLC6A2 SLC6A4	5.32e-06	2	53	2	DB00344
Drug	Atomoxetine	SLC6A2 SLC6A4	5.32e-06	2	53	2	DB00289
Drug	Milnacipran	SLC6A2 SLC6A4	5.32e-06	2	53	2	DB04896
Drug	Amineptine	SLC6A2 SLC6A4	5.32e-06	2	53	2	DB04836
Drug	nisoxetine	SLC6A2 SLC6A4	5.32e-06	2	53	2	ctd:C011386
Drug	nipecotic acid	SLC6A1 SLC6A6 GABRG3 GABRA5	9.43e-06	57	53	4	CID000004498
Drug	lormetazepam	GABRG3 MCOLN1 GABRA5	9.48e-06	18	53	3	CID000013314
Drug	AC1N65YL	SLC6A4 GABRG3 GABRA5	1.32e-05	20	53	3	CID004229818
Drug	bicuculline methochloride	SLC6A1 GABRG3 GABRA5	1.54e-05	21	53	3	CID000123659
Drug	Nortriptyline	SLC6A2 SLC6A4 ABCB1	1.54e-05	21	53	3	ctd:D009661
Drug	taurine	SLC6A1 SLC6A2 SLC6A4 SLC6A6 GABRG3 GABRA5	1.58e-05	231	53	6	CID000001123
Drug	D-161 compound	SLC6A2 SLC6A4	1.59e-05	3	53	2	ctd:C532102
Drug	Mazindol	SLC6A2 SLC6A4	1.59e-05	3	53	2	DB00579
Drug	Dexmethylphenidate	SLC6A2 SLC6A4	1.59e-05	3	53	2	DB06701
Drug	Methylphenidate	SLC6A2 SLC6A4	1.59e-05	3	53	2	DB00422
Drug	Duloxetine	SLC6A2 SLC6A4	1.59e-05	3	53	2	DB00476
Drug	2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone	SLC6A2 SLC6A4	1.59e-05	3	53	2	ctd:C569113
Drug	Venlafaxine	SLC6A2 SLC6A4	1.59e-05	3	53	2	DB00285
Drug	2-(4-bromo-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine	SLC6A2 SLC6A4	1.59e-05	3	53	2	ctd:C000595926
Drug	4-fluoroamphetamine	SLC6A2 SLC6A4	1.59e-05	3	53	2	ctd:C040639
Drug	1,4-diazabicyclo[3.3.1]nonane	SLC6A2 SLC6A4	1.59e-05	3	53	2	CID015140257
Drug	Sibutramine	SLC6A2 SLC6A4	1.59e-05	3	53	2	DB01105
Drug	RTI-219	SLC6A2 SLC6A4	1.59e-05	3	53	2	CID010524711
Drug	NSC652297	SLC6A4 ABCB1	1.59e-05	3	53	2	CID000092781
Drug	2-(4-bromo-2,5-dimethoxyphenyl)ethylamine	SLC6A2 SLC6A4	1.59e-05	3	53	2	ctd:C079321
Drug	5-(2-aminopropyl)benzofuran	SLC6A2 SLC6A4	1.59e-05	3	53	2	ctd:C000608250
Drug	1-phenyl-2-(1-pyrrolidinyl)-1-pentanone	SLC6A2 SLC6A4	1.59e-05	3	53	2	ctd:C000592273
Drug	4-methoxymethamphetamine	SLC6A2 SLC6A4	1.59e-05	3	53	2	ctd:C060169
Drug	difluoropine	SLC6A2 SLC6A4	1.59e-05	3	53	2	CID000190851
Drug	2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine	SLC6A2 SLC6A4	1.59e-05	3	53	2	ctd:C554181
Drug	AC1Q5UBL	SLC6A1 SLC6A2 SLC6A4 GABRG3 GABRA5	2.27e-05	146	53	5	CID000005466
Drug	isonipecotic acid	SLC6A1 GABRG3 GABRA5	2.64e-05	25	53	3	CID000003773
Drug	CCD 1042	SLC6A1 GABRG3 GABRA5	2.64e-05	25	53	3	CID000038022
Drug	4-(4-Chlorophenyl)piperidine	SLC6A2 SLC6A4	3.18e-05	4	53	2	CID001203613
Drug	[18f]fmener-d2	SLC6A2 SLC6A4	3.18e-05	4	53	2	CID006914301
Drug	butriptyline	SLC6A2 SLC6A4	3.18e-05	4	53	2	CID000021771
Drug	Chlorpheniramine	SLC6A2 SLC6A4	3.18e-05	4	53	2	DB01114
Drug	indatraline	SLC6A2 SLC6A4	3.18e-05	4	53	2	ctd:C418119
Drug	Biogenic Monoamines	SLC6A2 SLC6A4	3.18e-05	4	53	2	ctd:D015306
Drug	clobazam	SLC6A1 GABRG3 GABRA5	4.17e-05	29	53	3	CID000002789
Drug	guvacine	SLC6A1 GABRG3 GABRA5	4.63e-05	30	53	3	CID000003532
Drug	His-pro-dkp	SLC6A1 SLC6A2 SLC6A4	5.11e-05	31	53	3	CID000065137
Drug	SKF89976A	SLC6A1 GABRG3 GABRA5	5.11e-05	31	53	3	CID000092409
Drug	endosulfan	GABRG3 SERINC3 ABCB1 GABRA5	5.28e-05	88	53	4	CID000003224
Drug	Phentermine	SLC6A2 SLC6A4	5.29e-05	5	53	2	DB00191
Drug	[11c]afa	SLC6A2 SLC6A4	5.29e-05	5	53	2	CID005352128
Drug	[11c]afm	SLC6A2 SLC6A4	5.29e-05	5	53	2	CID005352125
Drug	lortalamine	SLC6A2 SLC6A4	5.29e-05	5	53	2	CID000051047
Drug	[11c]afe	SLC6A2 SLC6A4	5.29e-05	5	53	2	CID005732447
Drug	3-aminopropylphosphinic acid	SLC6A1 GABRG3 GABRA5	5.63e-05	32	53	3	CID006335948
Drug	desmethylsertraline	SLC6A2 SLC6A4 ABCB1	6.77e-05	34	53	3	CID000114743
Drug	AC1L9NDJ	SLC6A2 SLC6A4	7.93e-05	6	53	2	CID000449667
Drug	Mianserin	SLC6A2 SLC6A4	7.93e-05	6	53	2	DB06148
Drug	Clomipramine	SLC6A2 SLC6A4	7.93e-05	6	53	2	DB01242
Drug	Escitalopram	SLC6A2 SLC6A4	7.93e-05	6	53	2	DB01175
Drug	sipatrigine	SLC6A1 SLC6A2 SLC6A4	8.75e-05	37	53	3	CID000060803
Drug	secobarbital	SLC6A1 GABRG3 GABRA5	8.75e-05	37	53	3	CID000005193
Drug	Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A	SLC6A6 GDPD5 PPP2R5A PAPPA GABRA5	9.44e-05	197	53	5	2879_UP
Drug	DMCM	SLC6A1 GABRG3 GABRA5	9.49e-05	38	53	3	CID000104999
Drug	beta-alanine	SLC6A1 SLC6A6 GABRG3 GABRA5	1.01e-04	104	53	4	CID000000239
Drug	zaleplon	SLC6A1 GABRG3 GABRA5	1.03e-04	39	53	3	CID000005719
Drug	tetrabenazine	SLC6A2 SLC6A4 ABCB1	1.11e-04	40	53	3	CID000006018
Drug	X3020	HAS1 ABCB1	1.11e-04	7	53	2	CID006445091
Drug	3,4-Methylenedioxymethamphetamine	SLC6A2 SLC6A4	1.11e-04	7	53	2	DB01454
Drug	MMDA	SLC6A2 SLC6A4	1.11e-04	7	53	2	DB01442
Drug	sarcosinamide	SLC6A2 ABCB1	1.11e-04	7	53	2	CID000151411
Drug	oracaine	SLC6A2 SLC6A4	1.11e-04	7	53	2	CID000004065
Drug	Pseudoephedrine	SLC6A2 SLC6A4	1.11e-04	7	53	2	DB00852
Drug	gaboxadol	SLC6A1 GABRG3 GABRA5	1.19e-04	41	53	3	CID000003448
Drug	desvenlafaxine	SLC6A1 SLC6A2 SLC6A4	1.19e-04	41	53	3	CID000125017
Drug	zolpidem	SLC6A1 GABRG3 GABRA5	1.38e-04	43	53	3	CID000005732
Drug	mecoprop	SLC6A2 SLC6A4 SERINC3	1.47e-04	44	53	3	CID000007153
Drug	saclofen	SLC6A1 GABRG3 GABRA5	1.47e-04	44	53	3	CID000122150
Drug	CGP 36742	SLC6A1 GABRG3 GABRA5	1.47e-04	44	53	3	CID000130021
Drug	Amoxapine	SLC6A2 SLC6A4	1.48e-04	8	53	2	DB00543
Drug	RTI-121	SLC6A2 SLC6A4	1.48e-04	8	53	2	CID000122190
Drug	AC1L1GIZ	SLC6A2 SLC6A4	1.48e-04	8	53	2	CID000003703
Drug	Cocaine	SLC6A2 SLC6A4	1.48e-04	8	53	2	DB00907
Drug	tiagabine	SLC6A1 ABCB1	1.48e-04	8	53	2	ctd:C059205
Drug	Paroxetine	SLC6A2 SLC6A4	1.48e-04	8	53	2	DB00715
Drug	Octopamine	SLC6A2 SLC6A4	1.48e-04	8	53	2	ctd:D009655
Drug	isoguvacine	SLC6A1 GABRG3 GABRA5	1.58e-04	45	53	3	CID000003765
Drug	AC1O4QV6	SLC6A2 SLC6A4 NEUROG1	1.58e-04	45	53	3	CID006399008
Drug	amoxapine	SLC6A1 SLC6A2 SLC6A4	1.68e-04	46	53	3	CID000002170
Drug	heptachlor epoxide	GABRG3 SERINC3 GABRA5	1.68e-04	46	53	3	CID000013930
Drug	Tramadol	SLC6A2 SLC6A4	1.89e-04	9	53	2	DB00193
Drug	Nefazodone	SLC6A2 SLC6A4	1.89e-04	9	53	2	DB01149
Drug	phenethylamine	SLC6A2 SLC6A4	1.89e-04	9	53	2	ctd:C029261
Drug	xylamine	SLC6A2 SLC6A4	1.89e-04	9	53	2	CID000005706
Drug	vigabatrin	SLC6A1 GABRG3 GABRA5	2.03e-04	49	53	3	CID000005665
Drug	Methamphetamine	SLC6A2 SLC6A4	2.36e-04	10	53	2	DB01577
Drug	2-hydroxydesipramine	SLC6A2 SLC6A4	2.36e-04	10	53	2	CID000121249
Drug	methcathinone	SLC6A2 SLC6A4	2.36e-04	10	53	2	CID000001576
Drug	demethoxymitomycin A	SLC6A2 SLC6A4	2.36e-04	10	53	2	CID000037972
Disease	Isodicentric Chromosome 15 Syndrome	GABRG3 GABRA5	1.02e-05	3	55	2	C3711376
Disease	attention deficit hyperactivity disorder (implicated_via_orthology)	SLC6A2 PTCHD1 ADGRL2	1.94e-05	28	55	3	DOID:1094 (implicated_via_orthology)
Disease	Depressive Disorder, Treatment-Resistant	SLC6A2 SLC6A4	3.40e-05	5	55	2	C2063866
Disease	blood molybdenum measurement	NAA25 TMEM68 XKR4	4.94e-05	38	55	3	EFO_0007582
Disease	Recurrent depression	SLC6A2 SLC6A4	1.22e-04	9	55	2	C0221480
Disease	Alcoholic Intoxication, Chronic	SLC6A1 SLC6A2 SLC6A4 GABRG3 GABRA5	1.43e-04	268	55	5	C0001973
Disease	Schizophrenia	SLC6A1 SLC6A2 SLC6A4 NEUROG1 PLA2G4B LPAR1 ABCB1 GABRA5	2.18e-04	883	55	8	C0036341
Disease	depressive disorder (is_implicated_in)	SLC6A4 GABRA5	4.56e-04	17	55	2	DOID:1596 (is_implicated_in)
Disease	banks of the superior temporal sulcus volume measurement	TMEM68 PGBD5	4.56e-04	17	55	2	EFO_0010286
Disease	epilepsy (biomarker_via_orthology)	SLC6A1 ABCB1	7.00e-04	21	55	2	DOID:1826 (biomarker_via_orthology)
Disease	Visual seizure	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0270824
Disease	Epileptic drop attack	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0270846
Disease	Generalized seizures	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0234533
Disease	Clonic Seizures	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0234535
Disease	Vertiginous seizure	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0422855
Disease	Gustatory seizure	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0422854
Disease	Seizures, Somatosensory	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0422850
Disease	Olfactory seizure	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0422853
Disease	Seizures, Auditory	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0422852
Disease	Generalized Absence Seizures	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C4505436
Disease	Convulsive Seizures	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0751494
Disease	Seizures, Sensory	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0751496
Disease	Jacksonian Seizure	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0022333
Disease	Non-epileptic convulsion	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0751056
Disease	Atonic Absence Seizures	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0751123
Disease	Complex partial seizures	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0149958
Disease	Single Seizure	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C0751110
Disease	Epileptic Seizures	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C4317109
Disease	Nonepileptic Seizures	SLC6A1 SLC6A2 GABRA5	8.97e-04	101	55	3	C3495874
Disease	Tonic Seizures	SLC6A1 SLC6A2 GABRA5	9.23e-04	102	55	3	C0270844
Disease	Absence Seizures	SLC6A1 SLC6A2 GABRA5	9.23e-04	102	55	3	C4316903
Disease	Convulsions	SLC6A1 SLC6A2 GABRA5	9.23e-04	102	55	3	C4048158
Disease	Seizures, Focal	SLC6A1 SLC6A2 GABRA5	9.77e-04	104	55	3	C0751495
Disease	Myoclonic Seizures	SLC6A1 SLC6A2 GABRA5	9.77e-04	104	55	3	C4317123
Disease	Tonic - clonic seizures	SLC6A1 SLC6A2 GABRA5	9.77e-04	104	55	3	C0494475
Disease	Mental Depression	SLC6A1 SLC6A2 SLC6A4 ABCB1	1.30e-03	254	55	4	C0011570
Disease	bipolar disorder (is_implicated_in)	SLC6A4 GABRA5	1.34e-03	29	55	2	DOID:3312 (is_implicated_in)
Disease	diastolic blood pressure, unipolar depression	SLC6A2 NAA25	1.44e-03	30	55	2	EFO_0003761, EFO_0006336
Disease	Marijuana Abuse	SLC6A4 ABCB1	1.44e-03	30	55	2	C0024809
Disease	obsessive-compulsive symptom measurement	ATP13A4 TMTC1	1.53e-03	31	55	2	EFO_0007802
Disease	temporal lobe epilepsy (biomarker_via_orthology)	SLC6A1 ABCB1	1.53e-03	31	55	2	DOID:3328 (biomarker_via_orthology)
Disease	follicle stimulating hormone measurement	ATP13A4 ADGRL2	1.74e-03	33	55	2	EFO_0004768

Protein segments in the cluster

Peptide	Gene	Start	Entry
RALYFWNNEYILSLI	PPP2R5B	376	Q15173
SDIWLNLSSNLGYYF	ERICH6B	546	Q5W0A0
RLYLSENWLCFYSNI	GRAMD1C	101	Q8IYS0
LYWETNSLSNYQFLF	ATP13A4	921	Q4VNC1
NFLLSGSYDLSIRYW	FBXW10	466	Q5XX13
PLNWLLFNYYLTTCL	ABHD3	261	Q8WU67
QLYVWNNNFILRYSL	ADGRL2	376	O95490
FTWNALSAAQLYYLL	ADGRG7	541	Q96K78
NRYFYLLENLAWVKS	PDS5A	136	Q29RF7
NLFALYDENTKLWYA	JAK1	76	P23458
WLFSQLYLYSFISLF	MCOLN1	491	Q9GZU1
AAFLLIYASYALAFW	ABCB1	301	P08183
NFLLSGSYDLSIRYW	FBXW10B	466	O95170
IYFFIAASYAPWLNL	MMD2	111	Q8IY49
FAYNYIWALAETLRL	NEUROG1	136	Q92886
LYSDSYLVFWAIFNL	LPAR1	201	Q92633
NLNTSNWLYCWLYLF	EBPL	156	Q9BY08
AQLLYLAFLWDVYSG	GPR152	256	Q8TDT2
LFGTFNLVYWATYLN	GABRA5	436	P31644
LRDYASWNLSVNLYT	GDPD5	441	Q8WTR4
WNSTFLEEYSKLNYL	ITGA6	996	P23229
WSNLYAANLQDSLYW	PLA2G4B	501	P0C869
YSQLAQTTFWLRAYF	PAPPA	1076	Q13219
SGYNAWLSYELQLAA	PCDHA13	601	Q9Y5I0
WFAISIAINNAYILY	PGBD5	476	Q8N414
VVSWYLENYLANLFA	ILVBL	236	A1L0T0
TSFLLFNLVYWVGYL	GABRG3	451	Q99928
ALNNYNAEVWAYLAL	CFAP70	1061	Q5T0N1
YTSTGQLQWLLNTLY	C3orf20	721	Q8ND61
LYSLVNAFQWIQYSI	FLVCR1	116	Q9Y5Y0
LYRNNLLQQFLEAWY	HAS1	311	Q92839
DYYLNILDWSFQNLV	CDC20B	231	Q86Y33
WYFLNVFGLRSIYSL	EMC3	171	Q9P0I2
LDSAWQGYNATLLAY	KIF28P	96	B7ZC32
YQVYFLALAADWLQA	MFSD5	46	Q6N075
WLYLALNENSLESYL	PLEKHM2	96	Q8IWE5
WYANVFNSALYSLEV	TAS2R33	66	P0DSN6
IAWSLYYLFSSFTLN	SLC6A2	156	P23975
ILAWATYYLFQSFQK	SLC6A6	141	P31641
GLAAAVLSFWLNIYY	SLC6A1	126	P30531
SWFESYLNYLRKLNV	PTCHD1	586	Q96NR3
NTISYNWYATQLAFF	OR8K1	96	Q8NGG5
ALYFWNNEYILSLIE	PPP2R5A	371	Q15172
GATDLWLAASYYLQN	XKR7	71	Q5GH72
TYSYLLAFNVWLLLA	TMTC1	316	Q8IUR5
DYLNFANYLLWVFTP	TMEM68	36	Q96MH6
VLFANLAALFWYAYL	PXMP2	176	Q9NR77
EAYQWLNRSQFYFLT	WDR75	646	Q8IWA0
LENTALSALWYLYKA	XKR4	466	Q5GH76
LWYAALLSFTSAFYI	SERINC3	201	Q13530
TLNIYLLDSNLFWLY	TXNDC11	606	Q6PKC3
HNYSWLLFAALALYS	ZZEF1	1896	O43149
AWALYYLISSFTDQL	SLC6A4	181	P31645
LNGWYNATYFLLELF	TMEM216	26	Q9P0N5
LLKNSDDWQFYLTYF	NAA25	256	Q14CX7